← Back to headlines
Analysts Question Sustainability of Eli Lilly's Stock Surge Amid Falling Drug Prices
Market observers are debating whether Eli Lilly's strong stock performance can continue as pharmaceutical drug prices decline across the sector.
26 Aug, 13:33 — 26 Aug, 13:33
Sources
Showing 1 of 1 sources
